Company intelligence / Profile preview
Aquilon Pharma
Liège, Walloon Region, Belgiumaquilonpharma.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
The company has completed several clinical trials and is currently conducting a Phase II clinical trial for COVID-19 patients in the acute respiratory phase. They focus on improving the efficacy of inhaled drugs using their HP-Betadex technology.
- Therapeutic areas
- OtherPulmonologyInfectious Diseases
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Aquilon Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aquilon Pharma.